I'm using 2017 figure simply because 2018 figures might not reflect the reality of the new phase 1 expansion given the pre-existing quality issue of the products. i made an assumption that with the enhancement of phase 1 the cost of producing the products should be improved (versus the old production line)...so even not better but should be in line with the previous year's margin....happy to see others thoughts around this subject....i think it will be interesting...
- Forums
- ASX - By Stock
- CFO
- Ann: Successful Production Ramp-up of Phase 1 Expansion Start-up
Ann: Successful Production Ramp-up of Phase 1 Expansion Start-up, page-13
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CFO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online